Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000892917-13-000013
Filing Date
2013-06-03
Accepted
2013-06-03 19:07:00
Documents
1
Period of Report
2013-05-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3866
  Complete submission text file 0000892917-13-000013.txt   5392
Mailing Address 5 CENTERPOINTE DRIVE, SUITE 400 LAKE OSWEGO OR 97035
Business Address 5 CENTERPOINTE DRIVE, SUITE 400 LAKE OSWEGO OR 97035 971-2040382
CYTODYN INC (Issuer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: CO | Fiscal Year End: 0531
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5 CENTERPOINTE DRIVE, SUITE 400 LAKE OSWEGO OR 97305
Business Address
Mulholland Michael D. (Reporting) CIK: 0001257911 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-49908 | Film No.: 13889311